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In activated B lymphocytes, AID initiates antibody
variable (V) exon somatic hypermutation (SHM) for
affinity maturation in germinal centers (GCs) and
IgH switch (S) region DNA breaks (DSBs) for class-
switch recombination (CSR). To resolve long-stand-
ing questions, we have developed an in vivo assay
to study AID targeting of passenger sequences re-
placing a V exon. First, we find AID targets SHM hot-
spots within V exon and S region passengers at
similar frequencies and that the normal SHMprocess
frequently generates deletions, indicating that SHM
and CSR employ the same mechanism. Second,
AID mutates targets in diverse non-Ig passengers in
GC B cells at levels similar to those of V exons, defin-
itively establishing the V exon location as ‘‘privi-
leged’’ for SHM. Finally, Peyer’s patch GC B cells
generate a reservoir of V exons that are highly
mutated before selection for affinity maturation. We
discuss the implications of these findings for har-
nessing antibody diversification mechanisms.
INTRODUCTION
Antibodies are the secreted form of B cell antigen receptors
(BCRs), the basic subunit of which is a pair of identical immuno-
globulin (Ig) heavy (IgH) and light (IgL) chains. N-terminal regions
of IgH and IgL chains provide the antigen-binding variable (‘‘V’’)
region of antibodies. Ig V regions are encoded by exons (‘‘V
exons’’) assembled by V(D)J recombination during bone marrow
B cell development. V(D)J recombination creates diverse anti-
body repertoires by assembling multitudes of different germline
V, D, and J combinations and by diversifying junctions between
these segments through nucleotide deletions and insertions
(Alt et al., 2013). V exons contain three highly variable domains
termed complementarity-determining regions (CDRs), which en-1124 Cell 163, 1124–1137, November 19, 2015 ª2015 Elsevier Inc.code antigen-contact sites and determine binding specificity (Di
Noia and Neuberger, 2007). CDR1 and CDR2 are encoded by
germline V segments, whereas CDR3 is encoded by V(D)J junc-
tional regions and therefore has the greatest diversity (Hwang
et al., 2015). Conserved framework regions (FWRs) between
CDRs impart antibody structure. Due to junctional diversity,
about two-thirds of V exons are assembled out of frame and
do not encode proteins. These ‘‘non-productive’’ V exons are
often present in B cells in which the other IgH (and/or IgL) locus
is productively rearranged and supports development (Mosto-
slavsky et al., 2004).
The mouse expresses different antibody classes determined
by expressed IgH constant regions exons (CHs). The first devel-
opmentally expressed CH (Cm) generates primary B cells ex-
pressing IgM. Newly generated IgM-expressing B cells migrate
to peripheral lymphoid organs, where, upon antigen activation,
they further diversify primary antibody V exon repertoires by so-
matic hypermutation (SHM) and change expressed CH antibody
effector functions via IgH class-switch recombination (CSR)
(Hwang et al., 2015). SHM occurs in response to antigen-depen-
dent B cell activation in specialized lymphoid structures termed
germinal centers (GCs) (Victora and Nussenzweig, 2012). SHM
mainly introduces point mutations into V exons (Di Noia andNeu-
berger, 2007). GCB cells with SHMs that result in increased BCR
antigen-binding affinity are positively selected, leading to affinity
maturation, and those that decrease BCR affinity or cause loss of
BCR expression are negatively selected (Di Noia and Neuberger,
2007; Victora and Nussenzweig, 2012). IgH CSR occurs within or
outside GCs and can be activated in cultured IgM-expressing
primary B cells (Stavnezer et al., 2008). During CSR, DNA dou-
ble-strand breaks (DSBs) are introduced into long, repetitive
switch (S) regions that precede Cm (Sm) and each downstream
CH. Joining a donor Sm DSB to a downstream acceptor S region
DSB mediates CSR to IgG, IgE, or IgA (Hwang et al., 2015).
Both V exon SHM and IgH CSR are initiated by activation-
induced cytidine deaminase (AID) (Muramatsu et al., 2000), an
enzyme that deaminates cytosines (C) to uridines (U) in single-
stranded DNA. AID is targeted transcriptionally to V exons and
S regions, where it acts on both DNA strands (Alt et al., 2013).
Co-opted base excision repair (BER) or mismatch repair (MMR)
factors convert AID-initiated lesions into mutational or DSB out-
comes (Di Noia andNeuberger, 2007; Peled et al., 2008). Uridine/
guanine (U/G) mismatches, which are the result of AID activity,
are converted to transition or transversion mutations at initiating
C/G residues by replication over uracils or over an abasic site
upon uracil removal by BER (Di Noia and Neuberger, 2007).
MMR also generates transition or transversion mutations and
extends SHM to flanking adenine/thymidine (A/T) residues by
error prone DNA polymerase activity following excision of DNA
patches around AID-generated uracils (Peled et al., 2008).
DSBs can be generated by BER in the form of adjacent nicks
on both DNA strands or by MMR in the form of overlapping
gaps (Saribasak and Gearhart, 2012; Chahwan et al., 2012).
AID preferentially deaminates cytidines in short RGYW (R =
A/G, Y = C/T, W = A/T) or related motifs (Liu and Schatz, 2009;
Hackney et al., 2009). Compared to the genome, such motifs
are mildly enriched in certain V exons (Hackney et al., 2009).
AGCT, a canonical RGYW motif, occurs at high density in the
core of long, highly repetitive mammalian S regions, where its
palindromic sequence provides AID substrates on both DNA
strands (Han et al., 2011; Zarrin et al., 2004). However, AID-tar-
geting patterns on core S regions have not been measured
due to the repetitive S region nature.
While transcription targets AID to different S regions (Alt et al.,
2013), mechanisms that differentially target AID to sequences
within a V exon or between V exons and S regions have remained
enigmatic. AID targets both productive and non-productive V
exons during SHM at high frequency (103 mutations per base
pair) (Odegard and Schatz, 2006). Within V exons, SHMs are
focused at RGYW motifs in CDRs of both productive and non-
productive alleles (Di Noia and Neuberger, 2007; Do¨rner et al.,
1997; Betz et al., 1993a, 1993b; Wei et al., 2015). RGYW motifs
do not appear sufficient for targeting, since identical motifs
mutate less frequently in FWRs (Do¨rner et al., 1997; Wei et al.,
2015). In this regard, non-Ig sequences driven by Ig promoters
and enhancers in transgenes can, in some cases, undergo sub-
stantial SHM (Ye´lamos et al., 1995). However, as such transgene
results are variable and could reflect influences of integration site
and copy number, they have not generally been considered to
represent normal SHM processes (Yang and Schatz, 2007;
Maul and Gearhart, 2010a). Thus, the question of what mecha-
nisms enable high AID targeting within V exons and within
CDRs, in particular, has remained an enigma.
Another AID-targeting enigma comes from findings that B cells
or B cell lines activated in culture to undergo robust CSR have
not been found to undergo SHMof adjacent, transcribed V exons
(Nagaoka et al., 2002; Maul et al., 2014; Liu and Schatz, 2009).
Such findings led to the conclusion that differential mechanisms
target AID to V exons versus S regions (Maul and Gearhart,
2010b; Storb, 2014). While such mechanisms have been elusive,
one postulate is that these activities involve differential activation
of CSR versus SHM factors by AID (Muramatsu et al., 2007). V
exon SHM is considered to predominantly involve point muta-
tions (Di Noia and Neuberger, 2007) and rarely lead to DSBs
(Betz et al., 1993a). Estimates of the frequency of V exon DSBs
have been highly variable, likely due to the limited number of
sequences analyzed (Goossens et al., 1998, Betz et al., 1993a,C1993b; Bross et al., 2000; Briney et al., 2012). Thus, the question
of whether AID specifically mediates point mutation during SHM
andDSBs during CSR via distinct mechanisms has remained un-
resolved. Correspondingly, whether or not most V exon DSBs
are directly linked to AID-initiated SHM remains an important
question, given that deletions (and related insertions) can con-
tribute to antibody specificity, for example in certain extensively
mutated anti-HIV-1 broadly neutralizing antibodies (bnAb) (Wu
et al., 2011; Mascola and Haynes, 2013; Kepler et al., 2014).
Intestinal Peyer’s patch (PP) GCs are chronically present in
mice in the absence of specific immunization due to continual
stimulation by commensals and gut antigens (Casola et al.,
2004). Correspondingly, PP GC B cells with Vl exon SHMs are
found robustly in BCR-deficient mice that express the Epstein
Barr Virus protein LMP2a as a BCR signaling surrogate, indi-
cating that SHM occurs in PP GC B cells in the absence of
BCR engagement with antigen (Casola et al., 2004). In this re-
gard, intestinal B cell development and primary antibody diversi-
fication occurs in sheep, cattle, pigs, chicken, and rabbits (Lan-
ning and Knight, 2005) and has also been implicated in the
mouse (Wesemann et al., 2013). Thus, it is conceivable that
mouse PP GCs, beyond initiating antigen-specific responses,
may also undergo SHM via antigen-independent stimulation to
further expand primary BCR repertoires (Lanning and Knight,
2005; Casola et al., 2004). However, the degree to which
SHMs are selected by specific antigens in V exon repertoires
of PP GC B cells that express a functional BCR has not been
addressed.
To elucidate roles of V(D)J exon and S region sequences in
AID-targeting and DSB versus mutational outcomes in mouse
GC B and CSR-activated B cells, we developed an efficient
approach to measure AID activity on a fixed ‘‘productive’’ IgH
V(D)J exon allele, versus an array of test sequences driven by
the same promoter on the other ‘‘passenger’’ allele. This
approach has provided unanticipated insight into long-standing
questions regarding AID targeting and outcome during SHM
and CSR.
RESULTS
A V(D)J Replacement Passenger Allele System
We developed an efficient V(D)J passenger allele system to
test the influence of substrate sequences on AID targeting and
the outcome of such activity in mouse GC B cells or CSR-
activated cultured B cells (Figures 1A and S1A). For this
approach, we generated an embryonic stem (ES) cell line with
a productive pre-assembled V(D)J allele encoding the IgH V re-
gion of the 4-hydroxy-3-nitrophenylacetyl (NP)-binding B1-8
antibody (VB1-8) inserted in place of the four IgH JH segments
(Sonoda et al., 1997). On the other ‘‘passenger’’ IgH allele of
these ‘‘VB1-8’’ ES cells, we inserted a puromycin-resistance
cassette in place of the four JHs. To generate VB1-8 ES
cells with different test passenger sequences, we replaced the
inserted puromycin-resistance cassette with a ‘‘passenger’’
cassette, which consisted of a VB1-8 promoter and leader
sequence containing a translation termination codon, followed
by test sequences (Figure 1A, bottom). Thus, as the passenger
test sequences cannot encode proteins, their SHM patternsell 163, 1124–1137, November 19, 2015 ª2015 Elsevier Inc. 1125
  #1            #2          #3           #4          #5           #6          
n=2040 n=1963 n=1949 n=1958 n=1973 n=1971
n=2020 n=2011 n=1971 n=2034 n=2031 n=2035
n=2040           n=1963         n=1949        n=1958        n=1973        n=1971       
n=2020        n=2011        n=1971        n=2034        n=2031       n=2035       
Pr
o 
(V
B
1-
8)
  
Pa
s 
(V
B
1-
8)
  
Splenic GC B cells 
 Patch GC B cells 
n=2043       n=2004         n=2021        n=2015        n=2093         n=2070  
n=2047        n=1944        n=1997        n=1970        n=1943         n=1942  
Pr
o 
(V
B
1-
8)
  
Pa
s 
(V
B
1-
8)
  
B 
0 1-2 Mut/seq: 11-20 21-30 
RAG-2 deficient blastocyst complementation 
V(D)J replaced 
ES cells 
Inject ES cells into 
RAG-2 deficient 
blastocysts 
All mature B and T 
cells derived from 
modified ES cells 
SHM of GC B cells from spleen and  Patch  
Short-term 
immunization  
Sort Germinal 
Center B cells 
Allele-specific 
sequencing 
VB1-8 Pro V pro. L 
Pas VB1-8  V pro. L 
A 
3-10 31-40 
0
1
2
3 p=0.009, one-tailed
0
1
2
3 p=0.021, one-tailed
Pro (VB1-8) Pas (VB1-8) 
PP
 G
C
 m
ut
at
io
n 
fr
eq
ue
nc
y/
sp
le
ni
c 
G
C
 
m
ut
at
io
n 
fr
eq
ue
nc
y 
  #1            #2          #3           #4          #5           #6         
Figure 1. V(D)J Replacement Passenger Allele System
(A) Top: RDBC generates chimeric mice whose mature B cells carry a fixed
VB1-8-productive allele and test sequences in the V(D)J passenger allele.
Bottom: assay of SHM of GC B cells from spleen and PP of immunized mice.
Pro, pas, V pro, and L represent productive allele, passenger allele, V pro-
moter, and leader sequence, respectively. Red lines across the leader
sequence and VB1-8 in the passenger allele represent a termination codon
and two nucleotide changes from productive VB1-8, respectively.
(B) Pie charts showing the proportion of sequences that have the indicated
number of mutations per sequence in productive and passenger VB1-8 alleles
from splenic GC B cells (top) and PP GC B cells (middle) of six independent
mice. The total number of sequence reads from eachmouse is indicated below
1126 Cell 163, 1124–1137, November 19, 2015 ª2015 Elsevier Inc.are not biased by antigen-specific B cell selection forces. VB1-8/
passenger ES clones are used for RAG-2-deficient blastocyst
complementation (‘‘RDBC;’’ Chen et al., 1993) to generate
chimeric mice in which all peripheral lymphocytes are derived
from the injected ES cells (Figure 1A, top). We induce SHM in
splenic GC B cells of VB1-8/passenger chimeras by short-term
immunization (10 days) with NP-chicken gamma globulin (NP-
CGG) or other immunogens to activate GC formation in the
absence of appreciable antigen-specific B cell selection (Weiss
et al., 1992). Following immunization, we purify GC B cells from
spleens and PP of individual RDBC chimeras and amplify
their productive VB1-8 and the passenger allele sequences via
allele-specific primers, sequence the products via next-gene-
ration high-throughput sequencing, and assay them for SHMs
(Figure 1A, bottom; Figure S1B).
Mutation Profiles of Productive and Passenger VB1-8
Alleles in Splenic GC B Cells
To validate the RDBC-based VB1-8/passenger approach, we
assayed a bona fide VB1-8 sequence as a passenger (Figure 1A,
bottom). Given the essentially identical sequence and transcrip-
tion control elements, we expected a similar frequency and
pattern of SHMs in productive and passenger alleles of splenic
GC B cells under non-selective immunization conditions. For
analysis, we compared mutations per sequence in productive
and passenger alleles from six different chimeras by breaking
them into six different mutation strata, ranging from 0 to 31–40
mutations/sequence and using pie charts to visualize overall
SHM levels for each mouse (Figures 1B and S1C). Both produc-
tive and passenger VB1-8 alleles were mutated substantially in
splenic GC B cells (Figure 1B, top), with levels far above back-
ground (Figures S1D and S1E; Table S1). While overall SHM
levels varied between different chimeras, productive and pas-
senger VB1-8 alleles in splenic GC B cells of a given chimera
had very similar SHM levels (Figure 1B, top; Figure S1F, left).
Moreover, productive and passenger VB1-8 alleles in GC B cells
from given chimeras had remarkably similar distributions of se-
quences across the six tested SHM strata (Figure 1B, top).
Kinetic Analysis of Hotspot Mutations with Increasing
Mutation Frequency
One of our major goals was to test for AID target hotspots in
various passenger sequences by assaying for them in se-
quences with low to high mutation levels. In this regard, dupli-
cate mutations that arise from independent targeting events at
hotspots when mutation levels are low may be difficult to distin-
guish from PCR repeats and, therefore, difficult to capture by
standard SHM analyses that exclude duplicates (e.g., Rada
et al., 2004). To counter this limitation, we developed an analysiseach pie chart. Bottom: ratios of the mutation frequencies of PP GC B cells to
mutation frequencies of splenic GC B cells (calculated within each mouse), for
productive VB1-8 (left) and passenger VB1-8 alleles (right). Ratios were
calculated for each of the six mice separately and displayed as the mean ± SD
of the six mice. One-sample Student’s t test was performed to test for the
significance of the difference of the mean from a hypothetical mean of 1.0
(labeled in blue dotted line). A one-tailed p value is shown.
See also Figure S1 and Table S1.
strategy that includes duplicates, but controls for PCR repeats
by analyzing 5 to 6 independent mouse replicates for each ex-
periment and then averaging mutation frequency of each nucle-
otide across replicates. In addition, comparing the mutation
pattern of sequences in low to high strata allowed us to visualize
hotspot emergence and ongoing accumulation and thus served
as a surrogate SHM kinetic analysis. For ease of presentation,
we present such ‘‘kinetic’’ analyses for productive and passen-
ger alleles in three representative bins (Figure 2A). The stratifica-
tion of sequences into narrower bins gives similar results and
conclusions (Figure S2A, left).
Combined analyses of sequence reads revealed three robust
hotspots in both productive and passenger VB1-8 alleles,
including the two C nucleotides on opposite DNA strands of the
AGCT motif in CDR3 (positions 454 and 455) and a C in an
RGYW (AGCA) motif in CDR2 (position 337) (Figure S2B, top).
These hotspots were apparent at low SHM levels (1–2 muta-
tions/sequence) and further accumulated in sequences with
intermediate (3–10 mutations/sequence) and high (11–30 muta-
tions/sequence) SHM levels. In the latter, they were mutated in
40%–60% of sequences (Figure 2A). AGCT motifs in FWR1 and
FW3, and certain RGYW motifs in CDR2 and CDR3, were lower
level hotspots in both productive and passenger alleles, which
was evident at intermediate mutation levels and more so in
highly mutated sequences, reaching mutation in 20%–40% of
sequences (Figure 2A). Within all productive and passenger se-
quences with high SHM levels, AGCT and RGYWmotifs contrib-
uted the most residues with mutations well above background;
those above background in non-RGYW motifs tended to occur
adjacent to CDRs, where they may have, in part, resulted from
SHM spreading from initiating G/C base pairs (bp) (Figure 2A).
Finally, the SHM frequency at each base pair of the productive
allele was highly correlated with that of the passenger allele at
each strata (Pearson correlation, r = 0.75–0.87) (Figure S2C).
Overall, these findings support a ‘‘hierarchical’’ SHM process
by which mutations are targeted preferentially to a few preferred
CDR hotspot motifs, followed by accumulation of mutations in
other AID target motifs sites and eventually in non-RGYW se-
quences that in part represent SHM spreading to other sites.
Peyer’s Patches GC B Cells Contain Highly Mutated, but
Unselected, BCR Repertoire
We also examined the VB1-8 productive and passenger alleles
in purified PP GC B cells from the same short-term immunized
chimeras described above. Again, productive and passenger
VB1-8 alleles in PPGCB cells of a given chimera had very similar
overall SHM levels (Figures 1B, middle; Figure S1F, left). A major
difference between SHMof productive and passenger VB1-8 se-
quences between splenic and PP GC B cells was that the fre-
quency of SHMs on each was substantially higher in PP GC B
cells than in splenic B cells (Figure 1B, bottom). PP GC B cells
also had a significantly greater percentage of highly mutated se-
quences (>20 mutations per sequence) than did splenic GC B
cells (Figure S1F, right). Notably, despite having accumulated
higher levels of SHMs, PP GC B cells exhibited very similar
SHM patterns to those of splenic GC B cells on both productive
and passenger alleles (Figures 2B and S2A, right; Figure S2B,
bottom). In particular, productive and passenger alleles in PPCGC B cells had the same major and lower level hotspots (Fig-
ure 2B) with the only minor difference being a slight dampening
of themoremajor hotspot levels on passenger versus productive
allele sequences (Figure 2B), which may reflect loss of some via
AID-initiated deletions (see below). Nevertheless, in PP GC B
cells there were high correlations between the mutation fre-
quencies at each base pair across each strata when comparing
productive alleles to the passenger alleles (Pearson correlation,
r = 0.71–0.85) (Figure S2D), or when comparing the productive
allele on PP GC B cells to the productive allele in splenic GC B
cells (Pearson correlation, r = 0.80–0.90) (Figure S2E). Thus, in
both splenic and PP GC B cells, SHM patterns reflect preferred
sites of AID activity on the VB1-8 sequence rather than selection
for a specific response. PP GC B cells of four unimmunized mice
showed similar hotspots and highly correlated SHMprofiles (Fig-
ures S1C, S2F, and S2G). These findings suggest that the BCR
repertoire of PP GC B cells may reflect SHM activity on a germ-
line V(D)J repertoire in the absence of antigen selection.
Regions that Are Highly Targeted for SHM Are Also
Highly Targeted for DSBs
We found deletions on average in about 8% of splenic and 19%
of PP GC B cell mutated passenger allele sequences, but only in
about 2% of the corresponding productive sequences (Figures
3A and 3B; Table S2A). Given that VB1-8 passenger and produc-
tive alleles accumulated SHMs similarly, the relative absence of
deletions in productive alleles likely represents negative cellular
selection against B cells with BCR-inactivating deletions. We
also did similar analysis of unique (excluding duplicates) se-
quences and reached the same conclusions (Figures S3A and
S3B; Table S2B). For both splenic and PP GC passenger VB1-
8 sequences, deletion frequency was directly related to SHM fre-
quency as sequences with higher levels of mutations had higher
levels of deletions (Figures S3C and S3D). In this regard, many
unique deletions in passenger VB1-8 alleles (Figures 3C and
3D) (and productive alleles; Figures S3E and S3F) had endpoints
that occurred in and around VB1-8 CDR sequences, the sites
that harbor the highest SHM levels (Figure 2). The location of
deletions endpoints versus SHMs along VB1-8 passenger se-
quences was highly correlated for both splenic GC B cell se-
quences (Figure 3E) and PP GC B cell sequences (Figure 3F).
Thus, AID targeting for SHMs in VB1-8 frequently generated
DSBs that were the precursors for deletions. Finally, we found
very low levels of insertions in the assayed VB1-8 productive
and passenger allele sequences (Figures S3G and S3H).
Non-Ig Sequences Target as Robust SHM as V Exons
To address the question of whether high-level SHM targeting is
unique to V exon CDR sequences, we assayed SHM activity
on two non-Ig passenger allele substrates, an Escherichia coli
gpt gene (Figures 4 and S4) and a human b-globin gene (Figures
5 and S5), and compared SHM frequency on each passenger to
that of its corresponding productive VB1-8 allele. These non-Ig
sequence passengers were matched to the VB1-8 sequence in
size (360 bp) and also contained similar densities of AID-target-
ing motifs (23 RGYWs in the gpt sequence and 30 RGYWs in
the b-globin sequence, compared to 31 RGYWs in the VB1-8
sequence). Both bacterial gpt and b-globin passengers undergoell 163, 1124–1137, November 19, 2015 ª2015 Elsevier Inc. 1127
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Figure 2. SHM Profiles of VB1-8 Productive and Passenger Alleles
(A and B) Map of mutations (SHM profile) on the VB1-8 productive and passenger allele sequences in (A) splenic and (B) PP GC B cells. The y axis indicates the
mutation frequency at each nucleotide plotted as themean percent of sequences in the indicated strata that contain amutation at the indicated nucleotide ±SEM
(green shading indicates top error bar) from six independent mice. Orange and yellow bars mark the positions of AGCT and other RGYW motifs, respectively.
See also Figure S2.
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Figure 3. Deletions in VB1-8 Passenger
Allele
(A and B) Deletion frequency, calculated as the
percent of all mutated sequences that contain
deletions of VB1-8-productive and passenger al-
leles in (A) splenic and (B) PP GC B cells. Data are
represented as mean ± SD from six mice. Two-
tailed, paired t test p values are indicated.
(C and D) Map of unique deletions in VB1-8 pas-
senger allele from (C) splenic and (D) PP GC B
cells. Deletions are represented by lines whose
start and end indicate the start and end of the
deletion. Deletions from each of the six mice are
displayed with a line of a different color.
(E and F) The location of SHMs compared to the
location of deletion endpoints. The Pearson cor-
relation coefficient (r) between SHM frequency
and deletion (endpoint) frequency of each bin in (E)
splenic and (F) PP GC B cells is indicated.
See also Figure S3 and Table S2.SHM and have remarkably similar frequency distributions of mu-
tations per sequence andmutation frequencies to the productive
V(D)J allele (Figures 4A, 4B, 5A, 5B, S4A, and S5A). The mutation
frequency of each type of base substitution also was similar be-
tween non-Ig passengers and their corresponding VB1-8-pro-
ductive alleles (Figure S4B, top; Figure S5B, top). As for VB1-8
passengers, non-Ig passengers were more highly mutated in
PPGCB cells (Figures S4C and S5C). SHMprofiles of passenger
gpt and b-globin sequences show that hotspots occurredmainly
on RGYW motifs, including AGCTs, and that the same hotspots
were identified in non-Ig passenger sequences from splenic and
PP GC B cells (Figures 4C, 4D, 5C, and 5D). SHM of the most
robust hotspots in the non-Ig passengers (e.g., nucleotides G
of AGCT motif at position 253 in gpt and in position 292 in
b-globin) showed mutation frequencies comparable to those of
VB1-8 AGCTs in CDRs (e.g., nucleotides G at position 454 or
232) (Figures 4C, 4D, 5C, 5D, and S4B, bottom; Figure S5B, bot-
tom), with very similar ‘‘kinetics’’ of accumulation at differentCell 163, 1124–1137, Nostrata (Figures S4D, S4E, S5D, and
S5E). As for VB1-8 passengers, SHMpat-
terns in splenic GC B cells and PP GC B
cell sequence were very similar, despite
the latter accumulating higher levels of
mutations (Figures 4C, 4D, 5C, 5D, S4D,
S4E, S5D, and S5E). Also, like the VB1-
8 passenger, gpt and b-globin passenger
sequences underwent substantial levels
of deletions (Figures S4F, S4G, S5F,
and S5G), with endpoints highly corre-
lated with the location of SHMs (Figures
S4H, S4I, S5H, and S5I).
SHM Profile of S Regions in GC B
Cells
Analyses of SHM patterns of core mouse
S regions have been hindered by their
highly repetitive sequence (Rouaud
et al., 2013). We circumvented this limita-
tion by using a 756-bp truncation of Sm, which includes 426 bp
of the Sm core as a passenger, in both direct and inverted orien-
tations (‘‘cSm’’ and ‘‘inSm,’’ respectively; Figure 6A). For ana-
lyses, the cSm and inSm passengers were sequenced by Sanger
method, since we could not optimize high-throughput seq-
uencing through these highly repetitive sequences. Given the
more limited number of reads obtained by this approach, we
focused on SHM patterns, by pooling reads from six mice and
plotting for unique sequences the total number of mutations at
each base pair. For both cSm and inSm passengers, each of
the densely packed S region AGCT motifs are SHM hotspots in
both PP GC B cells (Figures 6B, S6A, and S6B) and splenic
GC B cells (Figure S6C). The symmetrical AID targeting of
SHMs of cytidines within AGCT palindromes in both transcrip-
tional directions likely facilitates S region DSBs as proposed
(Di Noia and Neuberger, 2007). Further supporting the impor-
tance of the AGCTs to DSB formation, the great majority of de-
letions in passenger cSm and inSm sequences map to regionsvember 19, 2015 ª2015 Elsevier Inc. 1129
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Figure 4. E. coli gpt Sequence Mutates as Frequently as VB1-8 Sequence
(A and B) Left: schematic of productive VB1-8 and passenger gpt alleles. Middle: pie charts showing the proportion of sequences that have the indicated (see
legend, right) number of mutations per sequence in productive VB1-8 and passenger gpt allele from (A) splenic and (B) PP GC B cells of six independent mice.
(C and D) SHM profiles of productive VB1-8 and passenger gpt allele from (C) splenic and (D) PP GC B cells from six mice. The y axis and other details are as
described for Figure 2. Data from mutation strata 3–10 mutation/sequence are shown.
See also Figure S4.
1130 Cell 163, 1124–1137, November 19, 2015 ª2015 Elsevier Inc.
C 
D 
B 
A Splenic GC B cells 
#b1          #b2          #b3           #b4         #b5            
 Patch GC B cells 
#b1          #b2          #b3           #b4         #b5            
n=2004        n=8035          n=6403         n=4499          n=7738            
n=1588        n=5659          n=5659         n=4231          n=6054            
n=1744        n=1952          n=1701         n=1970          n=1704            
Pa
s 
(
-g
lo
bi
n)
  
Pr
o 
(V
B
1-
8)
  
Pa
s 
(
-g
lo
bi
n)
  
Pr
o 
(V
B
1-
8)
  
VB1-8 LPro  
LPas  -globin 
Mut/seq: 
0 
1-2 
3-10 
11-20 
21-30 
31-40 
Mut/seq: 
0 
1-2 
3-10 
11-20 
21-30 
31-40 
LPas  -globin 
VB1-8 LPro  
n=1573        n=1972          n=1920         n=1827          n=1958            
Figure 5. Human b-globin Sequence Mutates as Frequently as VB1-8 Sequence
(A andB) Left: schematic of productive VB1-8 and passenger b-globin alleles. Middle: pie charts showing the proportion of sequences that have the indicated (see
legend, right) number of mutations per sequence in productive VB1-8 and passenger b-globin allele from (A) splenic and (B) PP GC B cells of five independent
mice.
(C and D) SHMprofiles of productive VB1-8 and passenger b-globin allele from (C) splenic and (D) PP GCB cells from fivemice. The y axis and other details are as
described for Figure 2. Data from mutation strata 3–10 mutation/sequence are shown.
See also Figure S5.
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B 
Figure 6. SHMProfiles andDeletionMaps of
Switch Regions
(A) Schematic of passenger core Sm (cSm) (left) and
inverted Sm (inSm) (right) alleles.
(B) Excerpt of SHM pattern of cSm (top) and inSm
(bottom) passengers from PP GC B cells. The y
axis indicates the total number of mutations. The
green open boxes show the positions of G-
stretches and C-stretches on cSm and inSm alleles,
respectively.
(C) Location of unique deletions in passenger cSm
(left) and inSm alleles (right). Deletions from splenic
GC B cells are depicted with red lines and from PP
GCB cells with black lines. For (B) and (C), the data
are pooled from six mice.
See also Figure S6.of high AGCT density which occur on opposite ends of the cSm
and inSm passenger sequences (Figures 6C, S6D, and S6E).
Finally, intervening G/C-rich stretches between AGCT hotspots
are rarely SHM targets in the passenger sequences (Figures
6B and S6C). As these G/C stretches are highly conserved in
mammalian S regions, our findings suggest that they may pro-
vide functions other than serving as targets for AID-initiated
lesions.
SHM of V Region in B Cells Activated in Culture
While S regions are AID targets in both GC and CSR-activated B
cells in culture, V exons reportedly are targeted by AID only in GC
B cells (Storb, 2014; Nagaoka et al., 2002; Maul et al., 2014),
leading to the lingering question of how AID is targeted to S re-
gions, but not adjacent IgH V exons, given that both are tran-
scribed (Storb, 2014). We re-evaluated this notion, now with
the insight that SHMs of VB1-8 in GC B cell sequences with
low SHM levels concentrate in two CDR3 AGCT hotspots (posi-
tions 454 and 455). Consistent with prior findings, SHM along the
length of productive and passenger VB1-8 sequences is close to
assay background in B cells stimulated in culture for 4 days with1132 Cell 163, 1124–1137, November 19, 2015 ª2015 Elsevier Inc.aCD40 plus IL-4 to induce CSR to Sg1
and Sε (Figures 7A, 7B, and S7A–S7C).
However, examination of SHM at VB1-8
hotspot nucleotides 454 and 455 of pro-
ductive and passenger VB1-8 alleles in
CSR-activated B cells reveals that they
undergo readily detectable and similar
levels of SHM (Figure 7B) and deletions
(Figures S7D–S7H). Indeed, comparison
of SHM profiles of productive and pas-
senger VB1-8 alleles of CSR-activated
B cells with those of GC B cell sequences
with similarly low SHM levels (1–2 muta-
tions/sequence), reveals highly similar
profiles and extent of hotspot nucleo-
tide 454 and 455 mutation (Figures 7C
and 7D).
To compare mutation frequencies of
hotspots in VB1-8 to those in S regions,
we assayed day 4 CSR-activated B cells
that harbored a productive VB1-8 and a passenger Sm. For these
analyses, we sequenced a portion of passenger cSm amenable
to high-throughput analysis (‘‘Pas 50 Sm’’) and also the same
portion of the endogenous Sm (‘‘Endo 50 Sm’’) (Figure 7E). The
overall mutation frequency of the Pas 50 Sm was much greater
(more than 7-fold) than that of the productive VB1-8 exon (Fig-
ures 7F, left; Figures S7I–S7K). However, comparison of the
SHM level of VB1-8 nucleotide 455 to that of a representative
S region AGCT hotspot at nucleotide 353 revealed them to be
quite similar (Figure 7F, right). Thus, the increased frequency of
overall SHM of Pas 50Sm compared to that of VB1-8 is generated
by themuch larger number of AGCT (and related) hotspots in Pas
50 Sm, rather than increased AID-activity at a given hotspot (Fig-
ure 7G). Notably, the endogenous 50 Sm sequence undergoes
SHM at AGCT hotspots at somewhat increased levels (approxi-
mately 3-fold) compared to that of AGCT motifs in the Pas 50Sm
(Figure 7F, right; Figure 7G). This increase could result from
different transcriptional promoters and/or effects of having an
adjacent full-length S region that could influence AID recruitment
via transcription-associated mechanisms and/or by promoting
longer stable R loops that increase AID access. Finally, cSm
A B 
C 
D 
E F 
G 
(legend on next page)
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passenger sequences undergo internal deletions (Figures S7L–
S7P) and support robust CSR-like events to Sε in about 20%
of the day 4 activated B cells (Figures S7Q and S7R). As Sanger
sequencing in GC B cells indicated that SHM frequency 50 Sm
AGCT hotspots were similar to that of such hotspots across
core Sm (Figure S6A), we concluded that relatively low SHM
levels of individual AGCT motifs in cSm collectively are sufficient
to drive CSR.
DISCUSSION
We describe a rapid passenger allele approach to test intrinsic
capacity and preferences of AID to induce SHMs and DSBs
within test sequences that replace a non-productive IgH V
exon. A key feature of the approach is lack of cellular selection
for or against mutations and deletions, enabling insights into
roles of substrate sequences in AID-targeting. In this regard,
the assay uses short immunization protocols that do not activate
affinity maturation; thus, SHM patterns on identical productive
and passenger V exon sequences in GC B cells are remarkably
similar, both in extent and detail. This assay feature allows
use of the same productive allele to standardize overall SHM
experienced by different passengers in different experiments.
Additional assay innovations include retaining all recovered se-
quences for analysis and relying on multiple biological replicates
to validate conclusions, allowing detection of AID hotspots even
at low overall SHM levels, such as those early in an immune
response or the previously unappreciated V exon SHMs in
cultured CSR-activated B cells. Also, by dividing recovered se-
quences into mutational strata, we can estimate relative muta-
tional kinetics at which SHMs of a particular nucleotide appear,
revealing early and late hotspots, as well as ‘‘spreading’’ of
SHMs from CDR hotspots to adjacent regions. This overall
approach allowed us to address long-standing questions in the
SHM and CSR field (see below). Finally, many of these powerful
assay features could be extended to dissect contributions of
sequence-intrinsic AID targeting to affinity maturation and anti-
body responses by using an antigen -specific productive V(D)J
exon and a matched passenger V(D)J exons in the context of
longer term immunizations.
Mechanisms that Target SHM Activity
We addressed the long-standing question of whether V exon se-
quences are required to recruit high-level SHM activity. OurFigure 7. SHM of the V Exon and S Region in B Cells Activated in Cultu
(A) Naive B cells of VB1-8 passenger mice were stimulated in culture for 4 days
(B)Mutation frequency of total nucleotides, nucleotide 454 and 455 of VB1-8 produ
sequence were included in the analysis. An unpaired t test was performed.
(C and D) SHM profiles of matched VB1-8-productive and passenger alleles in se
cells and (D) splenic GC B cells shown in Figure 2A. Peaks that have a SD great
(E) Naive B cells of cSm passenger mice were stimulated in culture for 4 days with a
(Pas 50 Sm) and endogenous Sm (Endo 50 Sm), indicated in blue lines, was analyze
(F) Mutation frequency over the entire indicated allele/region (left) and at individual
were included in the analysis. The mean values and fold change between each m
(G) SHM profiles of VB1-8-productive allele, Pas 50 Sm, and Endo 50 Sm of data
stimulations of cells from six independent mice. For (C), (D), and (G), data represe
are as described for Figure 2. For (B), (C), (F), and (G), data shown are mutation
See also Figure S7.
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sequences in the endogenous V exon location have overall SHM
frequencies similar to V exons and that some of their AID target
motifs mutate at similar frequencies as the samemotifs in V exon
CDR sequences. These findings prove that high level SHM
targeting in GC B cells is not specific to V exons, or even CDR
sequences; establishing definitively that the V exon location is
privileged for SHM. Mechanisms that make V exon location priv-
ileged for AID targeting may involve linked enhancers (Odegard
and Schatz, 2006; Buerstedde et al., 2014; Rouaud et al.,
2013), adjacent AID recruitment motifs (Storb, 2014), or tran-
scriptional-related mechanisms, such as convergent sense/anti-
sense transcription (Meng et al., 2014). SHM versus CSR
specific AID-targeting factors were hypothesized based on the
notion that V exons do not undergo SHM in CSR-activated B
cells (Muramatsu et al., 2007); however, our finding that V exons
are targeted for SHM in CSR-activated B cells obviates a strict
requirement for such factors (see below).
It has generally been thought that CDRs are highly evolved to
target high SHM levels (e.g., Wei et al., 2015). Consistent with
this notion, AGCT or AGCA motifs in the V(D)J exon CDRs are
hotspots, while the samemotifs in FWRs are not (Figure 2). How-
ever, we found similar examples in the bacterial gpt sequence,
where one AGCT (position 253) was as strong a hotspot as those
in VB1-8 CDRs, while another was not (position 228) (Figures 4C
and 4D). Likewise, in the b-globin sequence, AACC at position
193 was a major hotspot, but the identical motif at position 262
was not (Figures 5C and 5D). Thus, the elements that can
enhance SHM at CDRs and/or suppress SHM at FWRs are not
specialized to V exons or to CDR sequences. Such relatively
recurrent hotspot sequence combinations are likely evolution-
arily selected for in CDRs and against in FWRs. In ongoing
studies, we are using the passenger system to test additional
sequence combinations flanking AGCT hotspots within other-
wise randomized synthetic sequences to ultimately elucidate se-
quences that define an AID hotspot in the V exon location.
SHMs and DSBs Are Targeted by the Same Mechanism
We now show that deletions occur frequently on highly mutated
V(D)J exons as part of a normal SHM process. In this regard, we
demonstrate a clear and direct relationship between SHM activ-
ity and DSB activity on a V exon, with the highest density and the
majority of deletion endpoints focused at locations of highest
level SHM (e.g., at AGCTs within CDR sequences). In addition,re
with aCD40 and IL4.
ctive and passenger alleles at day 4. All sequences that have 0–2mutations per
quences that contain 1–2 mutations/sequence from (C) day 4 CSR-activated B
er than the mean were excluded.
CD40 and IL4. The 50 region immediately upstream of the core in passenger Sm
d.
nucleotides indicated (right). All sequences that have 0–3mutations/sequence
ean are indicated.
shown in (F). For (B) and (F), data represent mean ± SD of six independent
nt mean frequency ± SEM of six independent mice. The y axis and other details
frequency at day 4 after subtraction of mutation frequency at day 0.
we found that this same relationship holds for non-Ig passenger
sequences. Taken together, our findings reveal that DSB gener-
ation within V(D)J exons is a common and normal outcome of
SHM activity. These findings answer a long-standing question
in the vaccine field regarding how bnAbs with Ig chains encoded
by V exons harboring deletions arise by showing that specialized
mechanisms are not necessary. Our findings that highly mutated
PP GC B cells contain abundant V exon deletions offers the po-
tential of developing new strategies to elicit such antibodies (see
below).
Features that Optimize S Region Sequences for CSR
By using a passenger Sm region, we are able to view in-depth the
SHM and DSB (deletion) pattern of core S regions. Mammalian
Sm contained large numbers of densely packed repeats closely
related to the sequence GGGGTGAGCT. Strikingly, within such
core Sm repeats, Cs on both strands of the canonical AGCT
hotspot duplexes were robustly targeted in both transcriptional
orientations in GC B cells. In this regard, DSBs/deletions in pas-
senger core Sm were highly enriched in regions of high AGCT
density, independent of transcriptional orientation, providing
direct support for the model that the high density of these palin-
dromic targets allows generation of closely spaced AID-initiated
lesions on both strands that then promote DSBs (Di Noia and
Neuberger, 2007). Notably, however, we found little or no target-
ing of Cs in Sm passengers that occurred opposite the conserved
template strand Sm repeat G-stretches, even if Sm transcriptional
orientation was reversed. This latter finding is consistent with
adjunct functions, perhaps in AID recruitment via R-loops (Shin-
kura et al., 2003), RNA-mediated mechanisms (Zheng et al.,
2015), and/or potential roles in S region synapsis (Maizels and
Gray, 2013).
Prior studies concluded that V exons are not SHM targets in B
cell activated in culture. Consistent with this notion, we found the
passenger Sm had an approximately 7-fold greater overall muta-
tion frequency than the V exon in CSR-activated B cells. How-
ever, AGCT hotspot motifs in V exons and S region passengers
were targeted at similar levels in these cells with the increased
overall SHM frequency of the S region passenger reflecting a
greater number of AGCT hotpots. Indeed, endogenous Sm region
AGCTmotifs are targeted only about 2-fold more frequently than
AGCT hotspots in passenger V exons. Notably, the pattern and
extent of V exon hotspot mutations in CSR-activated B cells
was similar to that of GC B cells early in the process of SHM
accumulation. Thus, we suggest that SHM is limited in CSR-acti-
vated B cells because they have not been exposed to sufficient
AID-activity, due to AID levels, length of exposure, or both. Still,
Sm passengers, while having similarly low-level SHM at AID hot-
spot motifs as GC B cells early in the process, were targeted for
sufficient DSBs to promote relatively robust joining to down-
stream S region sequences in a CSR-like process. Thus, the
great abundance of palindromic AGCT hotspots make S regions
highly sensitive substrates for generating CSR-initiating DSBs at
relatively low-level AID exposure. Accordingly, the limited num-
ber of highly targeted AGCT motifs in the V exon results in fewer
deletions/DSBs in the V exon compared to the S region. Based
on our findings, we propose that ability of S regions to undergo
DSBs with limited AID exposure evolved to allow efficient IgHCCSR, without generating substantial SHM of adjacent V exons
that could affect antibody affinity or specificity.
Implications for Generation of Highly Mutated
Antibodies during an Immune Response
Microbial antigens promote formation of PP GCs and IgL V exon
SHM without immunization (Gonza´lez-Ferna´ndez and Milstein,
1993) and even in the absence of antigen recognition via IgH or
IgL chains in the context of a BCR (Casola et al., 2004). The latter
studies led to the hypothesis that chronic activation of PP GC B
cells expands primary V(D)J recombination-generated antibody
repertoires via extensive SHM in the absence of antigenic
engagement of BCR (Casola et al., 2004). Our studies support
this hypothesis by showing that productive and passenger IgH
VB1-8 alleles in PP GC B cells undergo similarly high levels
and specific patterns of SHMs, with the same set of major hot-
spots that reflect preferred AID SHM targets. Indeed, under
short-term immunization conditions, SHM patterns of VB1-8
productive and passenger sequences were highly similar be-
tween splenic and PP GC B cells. Moreover, each Ig or non-Ig
passenger, respectively, had similar SHM and deletion patterns
in splenic versus PP GC B cells, except that levels were higher in
the latter. Notably, primary hotspots in PP GC B cell productive
and passenger alleles become saturated at high SHM levels,
with additional SHMs accumulating in secondary hotspots or
non-hotspot regions, allowing further diversification that might
be enhanced by primary hotspot saturation. While our current
studies do not assay for theoretical contributions of endogenous
IgL chains, they clearly show that PP GC B cells harbor a diverse
IgH VB1-8 repertoire via high-level SHM in the absence of
obvious selection. This process could generate B cell lineages
that provide V exons with high levels of mutations and deletions
as substrates for further mutation and selection via antigen-spe-
cific responses, providing greater diversity for additional muta-
tional and selective forces. Our findings, coupled with prior find-
ings (Casola et al., 2004), raise the possibility of tapping the
highly mutated PP GC B cell antibody reservoir as an approach
to elicit anti-HIV1 bnAbs or other antibodies with abundant
SHMs and/or deletions.
EXPERIMENTAL PROCEDURES
Generation of Targeted ES Cells
An ES cell line containing a VB1-8-productive allele (Sonoda et al., 1997) and
a puromycin cassette in place of the V(D)J exon on the other allele was
generated. ES cell lines containing passenger alleles were generated by re-
placing the puromycin cassette with the respective passenger sequences
(see the Supplemental Experimental Procedures for details). Chimeric mice
were generated by RAG-2 blastocyst complementation (Chen et al., 1993).
Assays for SHM
GC B cells from spleen and PP were collected from 8- to 12-week-old mice
immunized with NP-CGG (N-5055A; Biosearch Technologies) for 10 days.
GC B cells were isolated from PPs and spleens of chimeras by flow cytometry
sorting of cells that are B220+ and Peanut Agglutinin (PNA) hi. B220+ PNA lo
cells were also collected during each sort and (along with ES cell DNA) served
as negative controls for SHM. For SHM analysis of CSR-activated B cells
in vitro, naive B cells collected from the spleen of 6- to 8-week-old mice
were stimulated with aCD40 and IL4 for 4 days (see the Supplemental Exper-
imental Procedures for details).ell 163, 1124–1137, November 19, 2015 ª2015 Elsevier Inc. 1135
PCR and Sequencing
The productive and passenger alleles were amplified in separate PCR reac-
tions using allele-specific primers. The products were sequenced by 2 3
250 bp Illumina MiSeq high-throughput sequencing (Illumina) or Sanger
sequencing systems, where indicated in the text. For Illumina high-throughput
sequencing, sequencing adapters and barcodes were added to the end of
DNA fragments by a second round of PCR (see the Supplemental Experi-
mental Procedures for details).
Data Analysis
A custom pipeline was used to process the sequencing data and to call muta-
tions. To compare the location of deletion endpoints versus SHMs along pas-
senger sequences, we measured the frequency of each within 10-bp bins and
calculated the Pearson correlation (r) between deletion endpoint frequency
and mutation frequency (see the Supplemental Experimental Procedures for
details). Statistical analysis is as stated in the figure legends.
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